Literature DB >> 6490823

Diagnosis of fastidious enteric adenoviruses 40 and 41 in stool specimens.

M Brown, M Petric, P J Middleton.   

Abstract

Thirty-five stool specimens, collected over a 14-week period from pediatric gastroenteritis patients and shown to contain adenovirus by electron microscopy, were inoculated onto 293 and HeLa cells. Virus isolates were characterized by serum neutralization and restriction endonuclease cleavage analysis of viral DNA from infected cells. Adenovirus was isolated upon primary inoculation of 293 cells from all 35 specimens shown to contain adenovirus by electron microscopy. Fastidious adenoviruses 40 and 41 (Ad40 and Ad41) were found in 17 (49%) of the stool specimens, and 4 of these specimens contained a conventional species (Ad1, Ad1, Ad18, Ad31) as well as Ad40. This was first manifest by the observation that four of the isolates which initially grew only in 293 cells acquired the capacity to grow in HeLa cells upon subsequent passage. In each case, the conventional species was undetectable by DNA analysis in the original inoculum but was selected in 293 cells and became the only one detectable by the second passage. Four other specimens, containing Ad1 or Ad31 alone, failed to grow initially in HeLa cells but did grow in 293 cells. The results of this study demonstrate therefore that (i) 293 cells are more sensitive than HeLa cells for the isolation of conventional as well as fastidious enteric adenovirus species and (ii) identification of viruses from patient specimens should involve minimal passage of the virus in cell culture, as a single passage can result in misdiagnosis of the virus associated with the infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490823      PMCID: PMC271324          DOI: 10.1128/jcm.20.3.334-338.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Ultrasensitive staining of nucleic acids with silver.

Authors:  J L Beidler; P R Hilliard; R L Rill
Journal:  Anal Biochem       Date:  1982-11-01       Impact factor: 3.365

2.  Antibodies to fastidious faecal adenoviruses (species 40 and 41) in sera from children.

Authors:  A H Kidd; J E Banatvala; J C de Jong
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

3.  Faecal adenoviruses from Glasgow babies. Studies on culture and identity.

Authors:  A H Kidd; B P Cosgrove; R A Brown; C R Madeley
Journal:  J Hyg (Lond)       Date:  1982-06

4.  Propagation and in vitro studies of previously non-cultivable enteral adenoviruses in 293 cells.

Authors:  H E Takiff; S E Straus; C F Garon
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

5.  Gastroenteritis associated with enteric type adenovirus in hospitalized infants.

Authors:  R H Yolken; F Lawrence; F Leister; H E Takiff; S E Strauss
Journal:  J Pediatr       Date:  1982-07       Impact factor: 4.406

6.  Outbreak of infantile gastroenteritis due to type 40 adenovirus.

Authors:  S Chiba; S Nakata; I Nakamura; K Taniguchi; S Urasawa; K Fujinaga; T Nakao
Journal:  Lancet       Date:  1983-10-22       Impact factor: 79.321

7.  Candidate adenoviruses 40 and 41: fastidious adenoviruses from human infant stool.

Authors:  J C de Jong; R Wigand; A H Kidd; G Wadell; J G Kapsenberg; C J Muzerie; A G Wermenbol; R G Firtzlaff
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

8.  Two new serotypes of enteric adenovirus causing infantile diarrhoea.

Authors:  I Uhnoo; G Wadell; L Svensson; M Johansson
Journal:  Dev Biol Stand       Date:  1983

9.  In vitro growth of some fastidious adenoviruses from stool specimens.

Authors:  A H Kidd; C R Madeley
Journal:  J Clin Pathol       Date:  1981-02       Impact factor: 3.411

10.  Isolation and identification of enteric adenoviruses.

Authors:  R Wigand; H G Baumeister; G Maass; J Kühn; H J Hammer
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

View more
  32 in total

1.  Effect of host cells on low- and medium-pressure UV inactivation of adenoviruses.

Authors:  Huiling Guo; Xiaona Chu; Jiangyong Hu
Journal:  Appl Environ Microbiol       Date:  2010-09-17       Impact factor: 4.792

2.  DNA hybridization for diagnosis of enteric adenovirus infection from directly spotted human fecal specimens.

Authors:  G Hammond; C Hannan; T Yeh; K Fischer; G Mauthe; S E Straus
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

3.  Sensitivity of subgroup F adenoviruses to interferon.

Authors:  C T Tiemessen; A H Kidd
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  A study of adenovirus gastroenteritis in the Tokyo area.

Authors:  H Ushijima; Y Eshita; K Araki; T Shinozaki; T Togo; Y Matsunaga
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

5.  Examination of uncommon clinical isolates of human adenoviruses by restriction endonuclease analysis.

Authors:  G W Hammond; G Mauthe; J Joshua; C K Hannan
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

6.  Selection of nonfastidious adenovirus species in 293 cells inoculated with stool specimens containing adenovirus 40.

Authors:  M Brown
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

7.  Adenovirus 41 growth in semi-permissive cells shows multiple-hit kinetics.

Authors:  C T Tiemessen; A H Kidd
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

8.  Restriction enzyme analysis of faecal adenoviruses in Newcastle upon Tyne.

Authors:  M M Willcocks; M J Carter; F R Laidler; C R Madeley
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

9.  Helper function of adenovirus 2 for adenovirus 41 antigen synthesis in semi-permissive and non-permissive cells.

Authors:  C T Tiemessen; A H Kidd
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

10.  Prevention by alpha-tocopherol and rutin of glutathione and ATP depletion induced by oxidized LDL in cultured endothelial cells.

Authors:  A Schmitt; R Salvayre; J Delchambre; A Nègre-Salvayre
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.